Date & Time
August 30, 12:00 PM ET / 9:00 AM PT
Webinar: Details provided upon RSVP approval
About the Event
Treatment options for Rheumatoid Arthritis fail 75% of the time. The problem lies in managing Stress Biology. Unfortunately there hasn’t been a way to measure it until now.
Inmedix has developed ANS Neuroscan, an easy to administer test for stress biology that…
- Improves RA remission rates by 216%
- 86% of rheumatologists surveyed say they need now
- Has a total addressable market that exceeds $3BN.
Join this webinar to hear from Inmedix CEO, Dr. Andrew J. Holman to hear about their plans to commercialize this breakthrough technology.